CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304.

Edelman, Martin J; Hodgson, Lydia; Rosenblatt, Paula Y; Christenson, Robert H; Vokes, Everett E; Wang, Xiaofei; Kratzke, Robert

Edelman, Martin J; Hodgson, Lydia; Rosenblatt, Paula Y; Christenson, Robert H; Vokes, Everett E; Wang, Xiaofei; Kratzke, Robert.

Affiliation

Edelman MJ; University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA. medelman@umm.edu

J Thorac Oncol ; 7(4): 649-54, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22425913

Subject(s)

Antigens, Neoplasm/blood; Biomarkers, Tumor/blood; Carcinoma, Non-Small-Cell Lung/mortality; Keratin-19/blood; Lung Neoplasms/mortality; Adult; Aged; Carcinoma, Non-Small-Cell Lung/blood; Carcinoma, Non-Small-Cell Lung/pathology; Female; Humans; Lung Neoplasms/blood; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Keratin-19 / Lung Neoplasms / Antigens, Neoplasm Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google